Table 1 Baseline characteristics stratified by kidney tests at medical facilities and health checkups in 30,669 men and 38,478 women.
Checkups | No checkup | |||
|---|---|---|---|---|
No kidney test | Kidney testsb | |||
Men | Number | 9474 | 9833 | 11,362 |
Age, years | 71 (65–76) | 62 (48–70) | 72 (65–78) | |
Use of anti-diabetic drugs, n (%) | 1222 (12.9) | 105 (1.1) | 2725 (24.0) | |
anti-hypertensive drugs | 4299 (45.4) | 835 (8.5) | 6566 (57.8) | |
lipid-lowering drugs | 1950 (20.6) | 203 (2.1) | 3009 (26.5) | |
anti-platelet drugs | 1677 (17.7) | 284 (2.9) | 3252 (28.6) | |
Kidney tests at checkupsa, n (%) | 9456 (99.8) | 0 (0.0) | 0 (0.0) | |
at medical facilitiesb | 5873 (62.0) | 0 (0.0) | 11,362 (100.0) | |
Current smokers, n (%) | 2302 (24.3) | NA | NA | |
Women | Number | 14,145 | 10,311 | 14,022 |
Age, years | 70 (65–76) | 65 (55–76) | 74 (66–81) | |
Use of anti-diabetic drugs, n (%) | 975 (6.9) | 110 (1.1) | 2,385 (17.0) | |
anti-hypertensive drugs | 5702 (40.3) | 1098 (10.6) | 7818 (55.8) | |
lipid-lowering drugs | 4520 (32.0) | 451 (4.4) | 5143 (36.7) | |
anti-platelet drugs | 1924 (13.6) | 339 (3.3) | 3246 (23.1) | |
Kidney tests at checkupsa, n (%) | 14,127 (99.9) | 0 (0.0) | 0 (0.0) | |
at medical facilitiesb | 8360 (59.1) | 0 (0.0) | 14,022 (100.0) | |
Current smokers, n (%) | 886 (6.3) | NA | NA | |
